Global Markets Direct Market Research Reports

TITLE	Actions
Psychosis (Central Nervous System) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Psychosis (Central Nervous System) - Drugs in Development, 2021 Summary Psychosis (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Psychosis pipeline landscape. The report provid...
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021 Summary Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Developmen...
T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 Summary T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 provides in ...
Claudin 18 (CLDN18) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Claudin 18 (CLDN18) - Drugs in Development, 2021 Summary Claudin 18 (CLDN18) - Drugs in Development, 2021 provides in depth analysis on Claudin 18 (CLDN18) targeted pipeline therapeutics. The report provides comprehensive in...
RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021 Summary RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021 provides in depth analysis on RNA Directed RNA Polymerase (EC 2.7.7.48) ta...
Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 Summary Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 provides an overview of the Pulmonary Fibrosis pipeline landscape. The report p...
Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 Summary Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Glycogen Storage Disease 1A pipeli...
Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Drugs in Development, 2021 ...
Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 Summary Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 provides in depth ...
Cells Expressing C Type Lectin Domain Family 12 Member A (Myeloid Inhibitory C Type Lectin Like Receptor or Dendritic Cell Associated Lectin 2 or C Type Lectin Like Molecule 1 or CLEC12A) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Cells Expressing C Type Lectin Domain Family 12 Member A (Myeloid Inhibitory C Type Lectin Like Receptor or Dendritic Cell Associated Lectin 2 or C Type Lectin Like Molecule 1 or CLEC12A) - Drugs in Development, 2021 Summary ...
Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Pulmonary Hypertension pipeline landscape. ...
Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021 Summary Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Inherited Mitochondria...
Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 Summary Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 provides in depth analysis on Niemann Pick C1 Like Protein 1 (NPC1L1) targeted...
Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021 Summary Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H ...
Cells Expressing Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Cells Expressing Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Drugs in Development, 2021 Summary Cells Expressing Folate Recep...
Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021 Summary Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021 provides an overview of the Pulmonary Inflammation pipeline landscape. ...
X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 Summary X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the X-Linked SCID pipeline landscape. The report prov...
Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 Summary Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 provides in dept...
CX3C Chemokine Receptor 1 (Beta Chemokine Receptor Like 1 or CMK BRL1 or Fractalkine Receptor or G Protein Coupled Receptor 13 or V28 or GPR13 or CX3CR1) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct CX3C Chemokine Receptor 1 (Beta Chemokine Receptor Like 1 or CMK BRL1 or Fractalkine Receptor or G Protein Coupled Receptor 13 or V28 or GPR13 or CX3CR1) - Drugs in Development, 2021 Summary CX3C Chemokine Receptor 1 (Beta C...
Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021 Summary Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021 provides i...

We are on:

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *

TITLE	Actions
Psychosis (Central Nervous System) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Psychosis (Central Nervous System) - Drugs in Development, 2021 Summary Psychosis (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Psychosis pipeline landscape. The report provid...
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Development, 2021 Summary Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type B (Genetic Disorders) - Drugs in Developmen...
T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 Summary T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 provides in ...
Claudin 18 (CLDN18) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Claudin 18 (CLDN18) - Drugs in Development, 2021 Summary Claudin 18 (CLDN18) - Drugs in Development, 2021 provides in depth analysis on Claudin 18 (CLDN18) targeted pipeline therapeutics. The report provides comprehensive in...
RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021 Summary RNA Directed RNA Polymerase (EC 2.7.7.48) - Drugs in Development, 2021 provides in depth analysis on RNA Directed RNA Polymerase (EC 2.7.7.48) ta...
Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 Summary Pulmonary Fibrosis (Respiratory) - Drugs in Development, 2021 provides an overview of the Pulmonary Fibrosis pipeline landscape. The report p...
Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 Summary Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Glycogen Storage Disease 1A pipeli...
Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) - Drugs in Development, 2021 ...
Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 Summary Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021 provides in depth ...
Cells Expressing C Type Lectin Domain Family 12 Member A (Myeloid Inhibitory C Type Lectin Like Receptor or Dendritic Cell Associated Lectin 2 or C Type Lectin Like Molecule 1 or CLEC12A) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Cells Expressing C Type Lectin Domain Family 12 Member A (Myeloid Inhibitory C Type Lectin Like Receptor or Dendritic Cell Associated Lectin 2 or C Type Lectin Like Molecule 1 or CLEC12A) - Drugs in Development, 2021 Summary ...
Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Pulmonary Hypertension pipeline landscape. ...
Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021 Summary Inherited Mitochondrial Disorders (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Inherited Mitochondria...
Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 Summary Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 provides in depth analysis on Niemann Pick C1 Like Protein 1 (NPC1L1) targeted...
Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021 Summary Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H ...
Cells Expressing Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Cells Expressing Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Drugs in Development, 2021 Summary Cells Expressing Folate Recep...
Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021 Summary Pulmonary Inflammation (Respiratory) - Drugs in Development, 2021 provides an overview of the Pulmonary Inflammation pipeline landscape. ...
X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 2000 Onwards \| By Global Markets Direct X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 Summary X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the X-Linked SCID pipeline landscape. The report prov...
Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 Summary Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 provides in dept...
CX3C Chemokine Receptor 1 (Beta Chemokine Receptor Like 1 or CMK BRL1 or Fractalkine Receptor or G Protein Coupled Receptor 13 or V28 or GPR13 or CX3CR1) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct CX3C Chemokine Receptor 1 (Beta Chemokine Receptor Like 1 or CMK BRL1 or Fractalkine Receptor or G Protein Coupled Receptor 13 or V28 or GPR13 or CX3CR1) - Drugs in Development, 2021 Summary CX3C Chemokine Receptor 1 (Beta C...
Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021 Published in Apr 2021 \| US $ 3000 Onwards \| By Global Markets Direct Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021 Summary Exo Alpha Sialidase (Neuraminidase or Acetylneuraminidase or EC 3.2.1.18) - Drugs in Development, 2021 provides i...